Physician profile
David A Bell
NPI 1881795599
$1,170.79
in general payments reported to CMS, 2019-2025
16 companies · $90.79 in 2025
The $90.79 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.78 · 2020: $60.87 · 2021: $75.43 · 2022: $322 · 2023: $519 · 2024: $20.14 · 2025: $90.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $307.99 | 2022-2024 | Senza |
| Averitas Pharma INC. | $241.76 | 2023 | Qutenza |
| Coastal Medical Technologies LLC | $106.64 | 2023 | |
| Horizon Therapeutics Plc | $81.31 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $69.41 | 2022-2025 | Nuzyra |
| Medtronic, INC. | $66.92 | 2022-2023 | Intellis Adaptivestim |
| Treace Medical Concepts, INC. | $51.48 | 2023-2025 | |
| Integra Lifesciences Corporation | $45.33 | 2021-2022 | |
| Abbvie INC. | $42.77 | 2023 | Dalvance |
| Depuy Synthes Sales INC. | $32.82 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $30.74 | 2023 | Seglentis |
| Stryker Corporation | $28.36 | 2019 | |
| Wright Medical Technology, INC. | $26.57 | 2019 | |
| Zimmer Biomet Holdings, INC. | $18.28 | 2020 | |
| Grt US Holding, INC. | $13.04 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $7.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.